Effects of antioxidant supplementation Coenzyme Q10 in women with Metabolic Syndrome and liver fat

Not Applicable

Recruiting

• Conditions: Metabolic Syndrome and Hepatic steatosis; C18.452.394.968.500.570; C06.552.241; G03.673

• Registration Number: RBR-26cq7n
• Lead Sponsor: Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-06-21
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

women; age between 20 and 55 years; sedentary; not menopausal; Body mass index less than 40 kg / m2; carrier of Metabolic Syndrome; with hepatic steatosis.

Exclusion Criteria

current gestation / lactation; smoking; alcoholism; inflammatory rheumatologic, intestinal and hepatic diseases; confirmed cancer; polycystic ovary syndrome; confirmed diabetes mellitus (type 1 or 2); refractory arterial hypertension; thyroid disease; use of Ginkgo biloba and statins; Supplementation with vitamin E or CoQ10 in the last three months

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Metabolic Syndrome: evaluation of abdominal circumference, blood pressure, HDL-cholesterol, triglycerides and fasting glycemia.<br>Pre and post intervention evaluation through blood tests, anthropometrics and gauging.

Secondary Outcome Measures

Name	Time	Method
Hepatic steatosis: To quantify the degree of liver fat through magnetic resonance before and after intervention.